Hypothetical Switch of Anti-Vascular Endothelial Growth Factor in Neovascular Age-Related Macular Degeneration: An ARIES Post Hoc Analysis

INTRODUCTION: Switching to an alternative anti-vascular endothelial growth factor (anti-VEGF) agent has been suggested for patients with neovascular age-related macular degeneration (nAMD) who have a suboptimal response to initial therapy. However, post hoc analyses of some studies have shown that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuerksever, Cengiz, Somfai, Gábor Márk, Oesch, Susanne, Machewitz, Tobias, Hasler, Pascal W., Zweifel, Sandrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784022/
https://www.ncbi.nlm.nih.gov/pubmed/35066801
http://dx.doi.org/10.1007/s40123-021-00448-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784022/
https://www.ncbi.nlm.nih.gov/pubmed/35066801
http://dx.doi.org/10.1007/s40123-021-00448-w

Ejemplares similares